Additionally, EMT status in circulating tumor cells (CTCs) has been correlated with upregulated PD-L1 expression [322] and development of therapeutic resistance by phenotypic switching in NSCLC [323]. This evidence concerns the gene CD274 and non-small cell lung carcinoma.